Literature DB >> 27998181

Perspectives and experiences of patients with type 2 diabetes observing the Ramadan fast.

Hadi A Almansour1, Betty Chaar1, Bandana Saini1.   

Abstract

INTRODUCTION: Diabetes is a common chronic disease among Australians. Culturally and linguistically diverse groups are observed to have higher prevalence rates of diabetes. Continuing management needs adherence to medication and diet regimens. Religious practices such as fasting can affect diabetes management and medication use. Pharmacists as medication specialists have a significant role in helping people observing religious practices such as the Ramadan fast, which involves month-long absolute abstinence from food during daylight hours, to maintain good control over their condition.
OBJECTIVE: This study investigated the perspective of patients with type 2 diabetes (T2D) who undertake the fast of Ramadan, to understand their experiences, health-related needs and service preferences regarding diabetes management.
METHODS: A qualitative, exploratory design was used in this study. Data collection comprised the conduct of semi-structured interviews with a purposive convenient sample of patients in areas of ethnic diversity in Sydney, using a standardised interview guide. Interview data were transcribed verbatim and thematically analysed.
RESULTS: Twenty-five semi-structured interviews (68% males) among a heterogeneous sample of fasting T2D patients were conducted. Themes emerging from analysis of transcripts included issues relating to sociocultural pressure for T2D patients to fast; lack of awareness about the role of pharmacists and, most importantly, the need to train pharmacists in cultural sensitivity and clinical implications thereof.
CONCLUSIONS: Community awareness about the role of the pharmacists in assisting medication use and adjustment during fasting periods should be enhanced. Furthermore, community pharmacists need to be trained about the unique religious and sociocultural issues of patients with diabetes opting to observe spiritual rituals such as the Ramadan fast. Clinical education in this area should up-skill pharmacists to inculcate self-management behaviours in fasting T2D patients.

Entities:  

Keywords:  Ramadan; Type 2 diabetes; fasting; pharmacist; type 2 diabetes patients

Mesh:

Year:  2016        PMID: 27998181     DOI: 10.1080/13557858.2016.1269156

Source DB:  PubMed          Journal:  Ethn Health        ISSN: 1355-7858            Impact factor:   2.772


  5 in total

Review 1.  Ramadan Fasting and Maternal and Fetal Outcomes in Pregnant Women with Diabetes Mellitus: Literature Review.

Authors:  Shejil Kumar; Terrence Diamond
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-24       Impact factor: 6.055

2.  Efficacy and Safety of Use of the Fasting Algorithm for Singaporeans With Type 2 Diabetes (FAST) During Ramadan: A Prospective, Multicenter, Randomized Controlled Trial.

Authors:  Zheng Kang Lum; Zi Rui Khoo; Wei Yann See Toh; Shaikh Abdul Kader Kamaldeen; Abdul Shakoor; Keith Yu Kei Tsou; Daniel Ek Kwang Chew; Rinkoo Dalan; Sing Cheer Kwek; Noorani Othman; Joyce Xia Lian; Raden Nurheryany Bte Sunari; Joyce Yu-Chia Lee
Journal:  Ann Fam Med       Date:  2020-03       Impact factor: 5.166

3.  Experiences and views of people with diabetes during Ramadan fasting: A qualitative meta-synthesis.

Authors:  Jieying Liao; Tianfang Wang; Zhan Li; Haotian Xie; Shanshan Wang
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

4.  "I am my own doctor": A qualitative study of the perspectives and decision-making process of Muslims with diabetes on Ramadan fasting.

Authors:  Siham Bouchareb; Rabab Chrifou; Zohra Bourik; Giel Nijpels; Mohamed Hassanein; Marjan J Westerman; Petra J M Elders
Journal:  PLoS One       Date:  2022-03-04       Impact factor: 3.240

5.  Facilitators and barriers to the self-management of COPD: a qualitative study from rural Nepal.

Authors:  Uday Narayan Yadav; Jane Lloyd; Hassan Hosseinzadeh; Kedar Prasad Baral; Sagar Dahal; Narendra Bhatta; Mark Fort Harris
Journal:  BMJ Open       Date:  2020-03-09       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.